Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling

J Pain
August 2008
https://www.ncbi.nlm.nih.gov/pubmed/18468954

Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report

J Pain Symptom Manage
January 2005
https://www.sciencedirect.com/science/article/pii/S0885392404003914

Treating chronic pain with low dose naltrexone and ultralow dose naltrexone: a review paper

Journal of Pain Management and Therapy
01 February 2019
https://www.alliedacademies.org/articles/treating-chronic-pain-with-low-dose-naltrexone-and-ultralow-dose-naltrexonea-review-paper-11183.html

Very low dose naltrexone in opioid detoxification: a double-blind, randomized clinical trial of efficacy and safety

Toxicol Res
21 November 2019
https://pubmed.ncbi.nlm.nih.gov/32042711/

Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex

J Pain
June 2005
https://pubmed.ncbi.nlm.nih.gov/15943961/

Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study

Dig Dis Sci
November 2006
https://pubmed.ncbi.nlm.nih.gov/17080248/

Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Cottel shares case studies of patients:

36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly. 

Paul Anderson, NMD - Case Studies (2017 Conference) (LDN, low dose naltrexone)

The first case is an oncology patient, a 47 year old female with colorectal cancer.  This lady presented herself while halfway through standard cancer treatment.  Dr Anderson added many adjunct therapies as well as Low Dose Naltrexone and the patients tumour markers reduced for the first time.

John Kim, MD - Ultra Low Dose Naltrexone, Micro Dosing (2018 Conference) (LDN, low dose naltrexone)